Merck Tbk PT

Merck Tbk PT EBITDA per Employee

The EBITDA per Employee of Merck Tbk PT (MERK.JK) as of Oct 22, 2026 is 852.22 M IDR. In the previous year, EBITDA per Employee was 534.97 M IDR — a change of 59.30% (higher).

EBITDA per Employee

852.22 MIDR

YoY

59.30%

Last updated:

EBITDA per Employee of Merck Tbk PT is 2025 852.22 M IDR. EBITDA per Employee of Merck Tbk PT was 2024 534.97 M IDR. It decreases by 59.30% higher compared to the previous year.

The Merck Tbk PT EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
132.57 M IDR
Jan 1, 2019
341.81 M IDR
Jan 1, 2020
317.58 M IDR
Jan 1, 2021
536.45 M IDR
Jan 1, 2022
658.83 M IDR
Jan 1, 2023
554.46 M IDR
Jan 1, 2024
534.97 M IDR
Jan 1, 2025
852.22 M IDR
The Merck Tbk PT EBITDA per Employee history
YEAREBITDA per EmployeeYoY
852.22 MIDR+59.30%
534.97 MIDR-3.51%
554.46 MIDR-15.84%
658.83 MIDR+22.81%
536.45 MIDR+68.92%
317.58 MIDR-7.09%
341.81 MIDR+157.84%
132.57 MIDR-76.43%
562.41 MIDR-2.29%
575.60 MIDR+13.80%
505.82 MIDR-6.53%
541.18 MIDR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT generates revenue through its Biopharma segment, which focuses on ethical pharmaceutical products for serious diseases. The company also earns from Consumer Health, offering over-the-counter products that support personal wellness and family planning needs. Its 'Others' segment includes additional business activities. The firm serves healthcare providers, pharmacies, and individual consumers seeking personalized treatments and accessible health solutions. Biopharma targets medical professionals and hospitals with specialized treatments for critical conditions. Consumer Health products are sold directly to consumers through retail channels for daily health management. The company's business model relies on delivering tailored healthcare solutions across its three operational segments to meet diverse market demands. Merck Tbk PT's revenue streams are structured around pharmaceutical innovations and consumer health products. Ethical products in Biopharma address unmet medical needs, while over-the-counter offerings in Consumer Health cater to everyday health requirements. The firm's focus on personalized care ensures consistent demand from both professional and individual customers. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

EBITDA per Employee of Merck Tbk PT is 852.22 M IDR in 2025.

EBITDA per Employee of Merck Tbk PT changed from 534.97 M IDR to 852.22 M IDR, representing a 59.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's IDR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Merck Tbk PT historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Merck Tbk PT

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Merck Tbk PT